We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vindon H. | LSE:VDN | London | Ordinary Share | GB00B06N4S86 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSBS TIDMVDN
RNS Number : 8839J
Source BioScience PLC
22 July 2013
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Identity of the party to the offer making the disclosure: Source Bioscience PLC ("SBS") ----------------------------------------------------------------------------------- --------------------------------- (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient ----------------------------------------------------------------------------------- --------------------------------- (c) Name of offeror/offeree in relation to whose relevant securities this form Vindon Healthcare PLC ("Vindon") relates: Use a separate form for each party to the offer ----------------------------------------------------------------------------------- --------------------------------- (d) Is the party to the offer making the disclosure the offeror or the offeree? OFFEROR ----------------------------------------------------------------------------------- --------------------------------- (e) Date position held: 22 July 2013 ----------------------------------------------------------------------------------- --------------------------------- (f) Has the party previously disclosed, or is it today disclosing, under the Code NO in respect of any other party to this offer? ----------------------------------------------------------------------------------- --------------------------------- 2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary Shares of 1 pence each -------------------------------------------------- ---------------------------------------- Interests Short positions -------------------------------------------------- -------------------- ------------------ Number % Number % -------------------------------------------------- ----------- ------- ----------- ----- (1) Relevant securities owned and/or controlled: 150,000 0.2% nil nil -------------------------------------------------- ----------- ------- ----------- ----- (2) Derivatives (other than options): nil nil nil nil -------------------------------------------------- ----------- ------- ----------- ----- (3) Options and agreements to purchase/sell: nil nil nil nil -------------------------------------------------- ----------- ------- ----------- ----- TOTAL: 150,000 0.2% nil nil -------------------------------------------------- ----------- ------- ----------- -----
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities Class of relevant security in relation to which subscription right exists: None ---------------------------------------------------------------------------- ----- Details, including nature of the rights concerned and relevant percentages: None ---------------------------------------------------------------------------- -----
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(c) Irrevocable commitments and letters of intent Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code): ------------------------------------------------------------------------------------------------------------------------------------------------- Irrevocable commitments have been provided by the Directors of Vindon to SBS in respect of 21,929,249 ordinary shares of Vindon beneficially owned by them, representing 24.68%. No. of Percentage of Party Ordinary Vindon Healthcare Shares Issued Share Capital Richard Hughes 15,200,349 17.11 Martin Liam Ferguson 4,150,000 4.67 Thomas Patrick Jackson 2,273,000 2.56 Martin Burrill 300,000 0.34 Total 21,923,349 24.68 ------------------------ ----------- ------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- 3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure: ------------------------------------------------------------------------------------------ None ------------------------------------------------------------------------------------------
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.
Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: If there are no such agreements, arrangements or understandings, state "none" ------------------------------------------------------------------------------------------------ None ------------------------------------------------------------------------------------------------ (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" ---------------------------------------------------------------------------------------------- None ---------------------------------------------------------------------------------------------- (c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO ------------------------------------- --- Supplemental Form 8 (SBL) NO ------------------------------------- --- Date of disclosure: 22 July 2013 --------------------- -------------------- Contact name: Nick Ash --------------------- -------------------- Telephone number: +44 (0)115 973 9010 --------------------- --------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEEUUVNROSABUAR
1 Year Vindon Healthcare Chart |
1 Month Vindon Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions